T here are two driving forces that have led to a growing interest in economic evaluations of occupational health interventions [1] [2] [3] . First, health problems among the working population have a significant and far reaching socioeconomic impact. Second, resources for occupational health interventions are scarce, which necessitates that choices are made. In practice, occupational health professionals along with workers, worker representatives and company managers, are required to make choices on a daily basis. Economic evaluations are systematic comparisons of two or more health technologies, services or programs in terms of both costs and consequences. This simultaneous comparison of the costs and consequences provides insight into which intervention is worth doing over another. A societal perspective is traditionally recommended as the framework for economic evaluations as it takes, in principle, all costs and consequences into account 4 . For specific stakeholders, however, not all costs and consequences may be relevant, limiting the interpretability of results from a societal perspective for decisions at a local level. Therefore, to inform decisions at a local level, taking the perspective of a specific stakeholder, such as a company, may be warranted [5] [6] [7] . With regards to occupational health interventions, although success requires collaboration between occupational health professionals, workers, worker representatives and company managers, the final decision about funding programs or services within companies lies with the (top) managers.
The methodological quality of an economic evaluation reflects how high the risk of biased results is and consequently influences how useful the conclusions and recommendations are for decision makers. In a review of economic evaluations of occupational health and safety interventions in the health care setting, Niven 8 found that methodological rigor was lacking in nearly all of the identified publications. Tompa et al. 9 made a similar conclusion in their literature review of workplace based interventions. The former review, however, was limited to evaluations performed in the health care setting, and the latter was limited to those addressing musculoskeletal health problems. The methodological quality of economic evaluations from a company's perspective of occupational health interventions has not yet been systematically evaluated. In addition, the systematic appraisal of methodological quality has been hampered by a lack of a standardized criteria list 10 . Recently, such a criteria list has been developed and published 11 . Thus, the objective of our systematic review was to assess the methodological quality of economic evaluations of preventive interventions for workers from a company's perspective using a standardized criteria list.
Methods

Study design and search strategy
A systematic review was conducted of economic evaluations from a company's perspective and based on primary data. We conducted our primary search in EMBASE. com, a database that combines the recorded journal entries of Medline from 1966 to present and Embase from 1974 to present. The EMBASE.com search strategy was developed by an experienced search specialist at our institute and covered the period from 1966 to April 2007. The search strategy was structured as follows:
• Set 1 = (economic-evaluation/exp) AND (employee/exp OR employee* OR employer/exp OR employer* OR industrial-worker/exp OR worker* OR exp OR occupational-health-service/exp OR preventive-health-service/exp); • Set 4 = set 1 AND (productivity/exp OR absenteeism/exp OR return-to-work OR sick-leave OR job-performance/de OR work-resumption/de); • Set 5 = (Measur* OR valuing* OR valuation OR value* OR significance OR analys* OR estimat* OR assess* OR determinat* OR methodology/de OR accuracy/de); • Set 6 = (set 3 OR set 4) AND set 5; and • Final set of articles = set 2 OR set 6. Supplemental searches were conducted in the Cochrane NHS Economic Evaluation Database (NHS EED), the National Institute for Occupational Safety and Health (NIOSHTIC-2) database, and the Ryerson International Labour, Occupational Safety and Health Index (RILOSH) database. Additional articles were identified from reference lists and the researchers' own literature databases.
Study selection
Two reviewers (KU and MdB) independently determined the eligibility of studies on the basis of title, keywords and abstract. If uncertainty remained, the full text was reviewed. Differences in judgement were resolved through a consensus procedure. We selected studies based on the following seven criteria: (i) the study population consisted of working-age individuals; (ii) the intervention in question was a workplace or primary care service, technology or program targeting workers; (iii) the intervention was compared to an alternative; (iv) an outcome that reflected a worker's health-related production capacity was measured and valued in monetary terms; (v) at minimum, costs of intervention-related resource use were included; (vi) the study was reported in either Dutch or English; and (vii) the economic evaluation was conducted from a company's perspective. We excluded studies involving children, elderly, unemployed or mixed populations; interventions in hospitals or inpatient settings; and editorials, letters, articles that only reported the design of an economic evaluation but not its results, congress abstracts and reviews. Modelling studies were excluded because these studies have unique methodological issues compared to economic evaluations based on primary data.
Applied classification schemes
In order to manage the heterogeneous nature of the data, and to facilitate data analysis and summarization of the findings, three classification schemes were used. First, we categorized the interventions according to their aim with regards to prevention as follows 12 : primary -to decrease the risk for incurring or developing a health problem; secondary -to identify individuals at risk for a health problem through screening; tertiary -to prevent chronicity, cure, rehabilitation or recurrences of a health problem.
Secondly, we used the following five labels for study design 13 14 : randomized controlled trial; controlled before-and-after; uncontrolled before-and-after; case-control; and historical cohort. In particular, "controlled before-and-after" was used to encompass studies described as a non-randomized controlled trial or quasi-experimental controlled trial; "uncontrolled before-and-after" referred to designs with a single group pre-test and post-test; and "historical cohort" involved designs in which a retrospective analysis of differences between two alternatives was performed based on a review of records.
Thirdly, we labelled the economic evaluations using the conceptual matrix proposed by Drummond et al. 4 The type of economic evaluation is determined by the number of alternatives compared, if both costs and consequences are included, and how the consequences are expressed. In a cost-effectiveness analysis (CEA), the consequences are expressed in terms of a unit of effect such as pain, function or symptom severity. A costutility analysis (CUA) is a variant in which the unit of effect is quality-adjusted life years. In a cost-benefit analysis (CBA), all health consequences (i.e. benefits due to improved health, future health care costs avoided and increased productive output due to improved health status) are translated into a monetary value using principles of willingness-topay 4 . The label, financial appraisal, was used to denote economic evaluations in which the costs and consequences of two or more alternatives are compared, but where the monetary consequences were limited to changes in health care use and/or productivity valued using market prices.
Methodological quality assessment
The methodological quality of the included studies was evaluated using the CHEC-list, a 19-item assessment tool developed through a Delphi procedure involving 23 international experts in the field of health economics
11
. The CHEC-list represents a minimum set of methodological criteria that address internal and external validity aspects of individual economic evaluation studies. Eighteen of the quality criteria relate to internal validity issues regarding study design, conduct and analysis. Of these, five pertain to study design: the description of study population; description of the interventions that are being compared; the research question; the research design; and the time horizon (i.e. follow-up period) of the study. Eleven criteria relate to the conduct of the economic evaluation: selection and justification of the perspective for the analysis; identification, measurement and valuation of resource use (i.e. costs); identification, measurement and valuation of outcomes (i.e. consequences); adjustment for costs and outcomes occurring in the future (i.e. discounting); congruency between the presented data and conclusions; independence of the investigators; and a discussion of ethical and distributional issues. Two criteria address the issue of analysis, that is, were an incremental analysis of costs and outcomes and a sensitivity analysis performed. The former refers to an analysis involving a joint comparison of the difference in costs and difference in outcomes between the two interventions, and the latter to a testing of assumptions made in the main analysis. Finally, one criterion addresses external validity, namely, the generalizability of results
. The operationalizations of the criteria for the measurement and valuation of outcomes do not, in principle, pertain to health-related work productivity variables, such as sick leave or work presenteeism, for they are considered costs in an economic evaluation. However, given that in economic evaluations conducted from a company's perspective, the outcome of occupational health interventions is commonly expressed in these terms and translated into a monetary value 15 , we included health-related work productivity variables in the outcomes judgement. Furthermore, given that there were almost never any health outcomes considered in the economic evaluations of the included studies, this adaptation offered the opportunity of a more specific evaluation of how health-related work productivity was measured and valued. Consequently, we expanded the existing operationalizations. That is, we judged the use of insurance or workers' compensation databases for measurement negatively because the information is limited to that of approved cases. To judge the valuation of sick leave positively, a clear report of the physical units of sick leave for each group, the cost price for each unit of sick leave and the source of this cost price were required.
The methodology of each study was independently evaluated by a pair of reviewers. The use of the CHEC-list was piloted by all reviewers. For 33 of 34 studies, the pairing was KU and MdB/JRA/LL. The one exception 16 was reviewed by JRA and LL because KU and MdB were co-authors of the given study. The reviewers disagreed on 131 of the 646 quality scores (21%), and we used a consensus procedure to resolve the disagreements. Data from the quality appraisals were quantified per article and per item in terms of percentages of positive ratings. Trends in quality were examined over time periods and categories of health problems. We synthesized the findings descriptively.
Results
Study selection
Our primary search in EMBASE.com resulted in 1645 hits, and our searches in NHS EED, NIOSHTIC-2 and RILOSH in resulted in 166, 477 and 352 hits, respectively. From this total of 2640 hits, 100 duplicates were removed, resulting in 2540 articles to be screened. Of these, 2422 were excluded based on title, keywords and abstract, and the full papers of the remaining 118 articles were assessed. Thirty studies were included based on our selection criteria. Reasons for exclusion were: wrong population or focus (N = 477); not a comparative study (N = 1777); no work-related outcome (N = 176); no resource use-related costs (N = 21); language (N = 40); and economic evaluation conducted from a perspective other than company (N = 19). Twenty-nine of the included studies were identified in EMBASE.com, and one from RILOSH. The searches in NHS EED and NIOSHTIC-2 did not result in any additional studies. With an additional four articles identified ad hoc, a total of 34 studies were included in this review. Table 1 presents an overview of the selected studies according to health problem. The largest proportion of the studies (50%) focused on musculoskeletal disorders [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . Mental health problems, although a significant cause of work disability, were only addressed in two studies 30 31 . Table 2 provides a description of study populations, the intervention comparisons and outcomes. Working populations from diverse industry sectors were represented: health care 19 20 22 23 26 28 31-34 , manufacturing 24 35-38 , energy 21 39-41 , education 42 43 , finance 44 45 , government 27 46 , transport 16 29 , construction 18 , defense 25 , retail 17 , telecommunications 47 , and multiple sectors 30 48 49 . With the exception of influenza, no single intervention was consistently evaluated in the other subgroups of studies addressing the same health problem. Also, while all studies included an outcome reflecting healthrelated work productivity, few studies included a health effect, such as musculoskeletal pain, discomfort or fatigue 18 20 23 46 , function 23 , or mental health complaints, such as anxiety, helplessness or depression 23 . , and of these, three met greater than 75% of the criteria 30 33 36 . Six of the economic evaluations were based on data from randomized controlled trials 16 26 28 , 9% a payback period 20 22 26 , and 32% a benefit-to-cost ratio 21 25 37 47 ; two reported both negative and positive monetary benefits 18 23 and one reported both a cost-neutral and positive situation 32 . With the exception of three studies, none of the studies conducted a statistical analysis of the differences in costs or monetary benefits, or the joint cost-effect estimate: Hlobil et al. 16 and Proper et al. 46 applied a non-parametric bootstrapping technique, and Landstad et al. 22 integrated a regression model into their analysis of subgroups. 
General description of the studies
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Reference
16%
Musculoskeletal complaints, injuries & lacerations
Banco
17
RCT FA Total net savings for Group A stores was $245 per 100,000 man-hours/store and total net savings per year was $29,413 (NT); Compensation-related cases were virtually eliminated in the Group A stores; Total net savings for group B stores was $106 per 100,000 man-hours/store and total net savings per year was $12,773 (NT).
32%
Burdorf 18 Uncontrolled B&A FA Hydraulic clamp or vacuum unit reduced production costs per m2 road by 4-9%, ROI was 0.8-4.8 years, benefits of less sick leave and work performance reduction were €5/day per worker (NT); automated pump or silo/truck with pump increased production costs per m2 by 3-10% and benefits of less sick leave and work performance reduction was €6.7/day per worker (NT). (95% CI: -10; 830) per beat per minute decrease in sub-maximal HR; counselling neither more costly nor more effective for the public health recommendation for physical activity; counselling tending to be more costly, more effective for upper-extremity symptoms (NS). Controlled B&A FA Net benefits/savings were $6.4 to $25.98 per vaccinated employee based on labour costs alone (NT); net benefits/ savings were $89.3 to 237.8 when operating income also considered (NT); vaccination program cost saving for vaccination coverage above 20% and ILI rates above 10%.
68%
Samad 40 Controlled B&A FA Employer savings were US$53 per vaccinated employee when labour costs only were considered (NT); savings increased to US$899.70 when operating income of each employee was also considered (NT). Table 4 presents the percentage of studies meeting each quality criterion. Eight of the quality criteria were met by 50% or more of the studies: appropriate economic study design (item 4, 97%); identification of important and relevant outcomes (item 10, 85%); performance of an incremental analysis of costs and outcomes of alternatives performed (item 13, 79%); identification of important and relevant costs (item 7, 74%); selection of an appropriate time horizon (item 5, 62%); valuation of outcomes and congruency between conclusions and reported data (items 12 and 16, 53%); and discounting of all future costs and outcomes (items 14, 50%).
The most prevalent methodological shortcomings were: performance of a sensitivity analysis and discussion of the generalizability of findings (items 15 and 17, both 41%); selection of an appropriate perspective (item 6, 38%); clear description of the study population (item 1, 35%); clear description of competing alternatives (item 2, 32%); presentation of a well-defined research question in answerable form (item 3, 24%); appropriate measurement of outcomes (item 11, 26%); appropriate valuation of costs (item 9, 18%); appropriate measurement of costs (item 8, 15%); discussion of ethical and distributional issues (item 19, 12%); and declaration of funding information and absence of conflict of interest (item 18, 9%).
With regards to the methodological shortcomings, the main reason for a negative rating for the sensitivity analysis criterion (item 15) was that potential cost drivers were simply not tested 17 , or high risk for recall bias 25 39 47-49 . The criterion relating to appropriate valuation of costs was scored negatively if the cost prices or the reference year was not clearly stated, or if the main costs were not calculated on depleted sources 17-29 31 34 35 38 40-49 . A negative rating was given for appropriate measurement of costs if the physical units or the data collection method was not clearly stated, or if the validity of the instrument used to collect cost data was questionable 16 17 19-29 32 34 35 38-48 . In most cases, the criterion related to the discussion of ethical and distributional issues was rated negatively because neither issue was addressed 16 [45] [46] [47] . A comparison of the methodological quality over time revealed a trend of a higher proportion of the studies meeting the quality criteria over time (table 4) . While there are insufficient numbers of studies for each subgroup of health problems, a comparison of subgroups consisting of five or more studies suggested that the overall methodological quality of economic evaluations of influenza vaccines was higher than that of other health problems (table 5) . 
Discussion
Thirty-four studies were included in this systematic review of methodological quality. While a positive trend over time was observed, less than half of the studies met more than 50% of methodological quality criteria, and only three studies met more than 75% of the criteria. We discuss the implication of poor methodological quality, strategies to improve the quality of future economic evaluations, strengths and limitations of this current review, and additional considerations.
Implication of poor methodological quality
For practice, the main implication of poor methodological quality is that there is a risk that results are biased. Using the results from economic evaluations with poor methodological quality to advise companies on how to allocate resources for occupational health interventions may result in inappropriate decisions 50 . The fact that statistical analysis of the cost differences and joint cost-effect estimates was seldom conducted, adds to the risk of misleading conclusions. Of the studies which met less than 75% of the quality criteria and did not conduct a statistical analysis, 15 concluded that the intervention of interest was cost-effective 17 . We also note that the negative implications for decision-making is also strengthened by publication bias, which can lead to an overestimate of treatment effects
.
Strategies to improve the methodological quality of future economic evaluations Our findings of poor methodological quality are not unique to our set of studies. This problem has been signalled in, for example, reviews of economic evaluations including financial appraisals targeting other specified sets of occupational health interventions, mental health interventions, stroke interventions, and other health care interventions 8-10 52 53 . Across these reviews, common strategies have been proposed to improve the methodological quality of future economic evaluations, and these strategies are equally applicable here. In sum, the strategies can be targeted at the researcher, the journal or both. For researchers, acquiring better knowledge of key methodological principles underlying economic evaluations from basic training, key reference textbooks, use of practice guidelines or quality checklists, and collaboration with health technology assessment researchers or health economists are recommended. For journals, impetus for improvement may come from ensuring journal reviewers are adequately schooled in economic evaluation methodology, and by adopting checklists for submissions as is the policy of, for example, the British Medical Journal. For both, attention should be paid to reporting in terms of transparency by researchers and use of website capabilities by journals in response to space constraints.
Based on the findings of our review, specific attention should be paid to improving the following five aspects related to internal validity. It should be noted that each of these aspects have implications for generalizability 50 54 . First, economic evaluations from a company's perspective should include an explicit description of the study population and the competing alternatives. With regard to study population, a clear presentation of clinical characteristics, inclusion and exclusion criteria, and drop-outs during follow-up is required to know if potential biases may taint the findings 11 . Furthermore, company characteristics such as size and sector as well as descriptions of job functions should be provided. Explicit descriptions of the alternatives are needed in order to judge whether . Second, an explicit statement of the perspective is required as the chosen perspective influences the selection of costs and outcomes 4 . When a narrower perspective, such as a company's perspective is chosen, the rationale for not using the broader societal perspective should be provided. While economic evaluations for specific decision makers are necessary and warranted [5] [6] [7] , it may be short-sighted not to take note of the costs and consequences affecting other stakeholders as well as the broader socio-political context in which the study takes place. A presentation of all socially relevant costs and outcomes in a disaggregated form may facilitate the extrapolating findings to other settings 54 . Third, attention needs to be paid to how costs and outcomes are measured, and how costs are valued. For both costs and health-related work productivity outcomes, the measurement tools used for data collection should be clearly reported and the tools should be valid. In addition, the physical units of costs and changes in health-related work productivity should be reported. Caution needs to be exercised in limiting lost work productivity data to that extracted from insurance databases. This is because these data only reflect the lost work time of approved cases. In recent years, a number of measurement tools have been developed to measure changes in work productivity from health-related absenteeism and presenteeism 55 56 . The cost prices used for valuation along with their sources, and the index year of the evaluation need to be clearly stated. Whenever possible, cost items should be valued based on depleted sources as charges and tariffs do not always represent the actual unit costs 11 57 . For a similar reason, cost data from workers' compensation claims or other insurance forms should also be used with caution as the full cost of a claim is often not billed to the company in the form of higher insurance premiums 9 . Furthermore, costs and consequences beyond one year should be discounted, that is, reduced to reflect that what is spent or saved in the future should not weigh as heavily in the decision making process as what spent or saved today 4 . Fourth, economic evaluations require that assumptions are made. Thus, it is necessary to test these assumptions in a sensitivity analysis. All variables are, in theory, candidates for the sensitivity analysis. However, if the variables are certain or preliminary analyses have shown that their impact on the results is minimal, then these variables may be excluded. Again, authors should provide justification for their choices so that readers can judge the plausibility of tested parameters for themselves 4 . In economic evaluations from a company's perspective, testing the assumptions behind how the changes in healthrelated productivity are valued are particularly relevant as this is the main outcome of interest.
Fifth, greater attention needs to be paid to characterising the uncertainty around the cost estimates and joint cost-effect estimates. This characterization encompasses two aspects. The first is related to quantifying of the precision of the cost and joint costeffect estimates. Currently, non-parametric bootstrapping is the recommended statistical technique for dealing with the highly skewed nature of cost data 58 . The second relates to interpretation. New methods of visually representing uncertainty such as costeffectiveness acceptability curves have been developed in order to help occupational health decision-makers interpret the uncertainty 59 .
Strengths and limitations
The main strength of the study is that it is the first review focusing on the methodological quality of economic evaluations of occupational health interventions conducted from a company's perspective. Furthermore, we conducted the methodological appraisal using a standardized quality checklist based on consensus among experts in economic evaluation. With respect to limitations, although we systematically searched four databases as well as the reference lists of included studies and our own database, we cannot guarantee that we captured all eligible studies. However, given that our finding is not uncommon, we do not believe that our main conclusion and the relevance of the recommendations for improving the methodological quality in future economic evaluations would be significantly altered with additional studies.
Additional considerations
Two observations about the economic analyses warrant further attention by stakeholders in occupational health research. The first observation is that the predominant form of economic evaluation was a financial appraisal. From a health economics perspective, a financial appraisal represents a partial form of economic evaluation, and therefore, less appropriate for informing decisions. In particular, the incompleteness of financial appraisals can be traced back to the fact that the health benefits are not included in the monetary expression of the consequences by using principles of willingness-to-pay. The monetary consequences are limited to those related to health care use and increased productive output. From a practical standpoint, however, it may be that financial appraisal will suffice for company decision makers. Such an assumption should be tested as it means that the savings from improved health are ignored. The omission of health improvements from the equation may be related to the fact that methodology to value health improvement in monetary terms is still evolving. The second observation is that within the financial appraisals, the final expression of the economic benefit for the company was expressed in five different ways: net benefits or savings, return-on-investment, internal rate of return, payback period or benefit-to-cost ratio. An expression of the difference in monetary benefits and program costs (i.e. referred to as net benefits or saving in the included studies, and net present value in health economic terms) is preferred over ratios because the net present value is straightforward to calculate and interpret. Ratios are sensitive to what is placed in the numerator and denominator, and unless the contents of the numerator and denominator are clearly described, ratios from different studies cannot be meaningfully compared 4 .
Conclusion
While exceptions were identified, the overall methodological quality of the identified economic evaluations from a company's perspective was poor. In particular, attention should be paid to the measurement and valuation of costs, sensitivity analysis and characterization of uncertainty around the cost and cost-effect estimates. Also, the sufficiency of well-conducted financial appraisals for informing company decisions with regard to occupational health interventions should be tested.
